And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
False
News & media
And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
Debate current medical affairs
French journal Prescire have annual awards to commend the best therapeutic advances of the past year. The "Golden Pill" award which rewards new drugs for their clear advantage over existin
0
Cat:OffDutyForum:NewsMedia
Cat:OffDutyForum:NewsMediaDiscussion:98f47327-4695-422e-aff9-bb8fd2594714
Forums » Off duty » News & media » And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
Forums
»
Off duty
»
News & media
»
And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
|
And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
posted at 10/2/2012 12:43 PM GMT
on bmj.com
|
|
*Moderator*
Posts: 623
First: 7/4/2011 Last: 16/5/2012 |
French journal Prescire have annual awards to commend the best therapeutic advances of the past year. The "Golden Pill" award which rewards new drugs for their clear advantage over existing treatments, remains unfilled for the fourth year running. The publication also condemns new drugs on the market by handing them yellow and red cards to signify a drug's failings for providing difficult information to understand, fatal packaging, harms to unborn children, contradictory schedule instructions and medicines without out sufficient safety caps. Should we have more organisations like Prescire independently critiquing drugs that are on the market? Do these awards show that drug companies are flooding the market with drugs that are no better than ones before? Is there an extent to how innovative a pharma company can be? A full list of Golden Pill winners and honours list drugs since 1981 is athttp://english.prescrire.org/Docu/Archive/docus/2011PrescrireAwards.pdf. |
|
|
Re: And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
posted at 10/2/2012 2:54 PM GMT
on bmj.com
|
Posts: 838
First: 12/3/2010 Last: 15/5/2012 |
In the last ten years there have been only two awards, to : nitisinone (2006) for hereditary tyrosinemia type 1 and carbaglumic acid (2007) for N-acetylglutamate synthase deficiency Both orphan ailments, that we should be grateful there is treatment for, but I have to say that since the 80s when Hep B vaccine, captopril and acyclovir were on the red carpet, this is an exclusive list. That in half of the thirty years it has been running there has been no award means that this just isn't likely to make an Oscar sized splash! This may be the mode, as this study: http://www.policycures.org/downloads/The_new_landscape_of_neglected_disease_drug_development.pdf from the Wellcome Trust found in 2005 that there had only been 13 new neglected disease drugs since 1975. John |
Forums » Off duty » News & media » And the winner of the "Golden Pill" goes to...... no one! (for the fourth year running)
